Corporate Profile

CordLife India is a majority-owned subsidiary of CordLife Limited, a company listed on the Australian Securities Exchange. A winner of Technology Pioneer award conferred by the World Economic Forum, CordLife has accumulated more than 10 years of experience in stem cell processing and cryopreservation.

CordLife Limited owns and operates 3 state-of-the-art stem cell processing and cryopreservation facilities in India, Indonesia and the Philippines along with a network extending to other full-fledged facilities in Singapore, Hong Kong and Mainland China.

About CordLife’s Facility in India

CordLife India is the largest and most advanced cord blood facility in the country, with a storage capacity of up to 150,000 cord blood units. The state-of-the-art laboratory with full processing, testing and cryopreservation capabilities is equipped with continuous power back-up as well as the most-up-to-date security and surveillance systems. In addition, the building is specially designed to withstand any natural calamity.

Located in Kolkata and officially launched by Singapore Senior Minister and former Prime Minister Mr Goh Chok Tong, CordLife India is licensed by the Drug Controller General of India to collect cord blood units from all Indian states and cities.

Vision

At CordLife, it is our passion to be the name to be reckoned for safe banking of Umbilical Cord and Cord Blood derived Stem Cells through efficient Collection, optimum Processing, accurate Testing and uninterrupted Cryogenic Storage.

Mission

We aim to offer the highest possibility of successful adult stem cell therapy to give hope and save lives.

Intellectual Properties

Patent

US Patent 5,282,861
European Patent specification EP 0,560,279B1 The patents cover porous, three-dimensional devices made using a carbon skeleton with a metal coating and further protect the use of such devices for cell growth and expansion.

US patent number 6,440,734
"Methods and Devices for the Long-Term Culture of Progenitor Cells" The broad patents/applications cover the growth and expansion of blood stem cells (from marrow, peripheral blood and cord blood) in three dimensional devices.

US patent number 6,548,299
China Patent ZL 98 8 13230.6 "Lymphoid Tissue-Specific Cell Production From Hematopoietic Progenitor Cells In Three-Dimensional Devices" The broad patents/applications cover the production of a broad range of immune cells ex vivo in three-dimensional devices.

Patents Pending

"Cell Culture Spinner Flasks"
Series of pending patents covering the rotational spinner flask culture system for high cell growth performance.

"Methods and Devices for Obtaining Non-Hematopoietic Lineage Cells from Hematopoietic Progenitor Cells"
Pending patents covering a novel, multipotent stem cell isolated from blood/marrow that exhibits trans-differentiation capabilities into non-hematopoietic tissue, such as skin (epithelium), vessels (endothelium) and neurons.

"Cytokine-Free Growth and Maintenance of Progenitor Cells"
First-stage filing covering the growth and expansion of blood stem cells in media without cytokine augmentation.

"Cell Culture System"
Patent applications covering a combination of biocompatible 3-D cell culture scaffold and membrane technology yielding cell expansion.

Accreditation/Awards

Along with our associates, our Group's in-depth knowledge of the business is recognised by many world-class gold standards and government bodies such as the American Association of Blood Banks (AABB), International Organisation for Standardisation (ISO) and numerous government regulators. Our stringent quality system helps ensures that your baby’s stem cells are carefully processed and cryopreserved using rigorous protocols.

Accreditations and certifications attained by CordLife Limited and associates:

Drugs Controller General of India Certification India	ISO 9001:2008 Certification India	Technology Pioneer, World Economic Forum Switzerland
AABB Accreditation Singapore	Ministry of Health Certification Singapore	Good Distribution Practice for Medical Devices Certification Singapore
ISO 9001:2008 Certification Hong Kong	Ministry of Health (DEPKES) Certification Indonesia	ISO 9001:2008 Certification Indonesia
Department of Health Registration The Philippines	Beijing Cord Blood Bank China	Guangdong Cord Blood Bank China